VivoSim Labs, INC. (VIVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Annual

0 50K 100K 150K FY25: 144K FY26: 131K FY25 FY26

Gross Profit Annual

0 50K 100K 150K FY25: 139K FY26: 131K FY25 FY26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-15M -10M -5M 0 5M 10M 15M FY25: -12.6M FY26: -11.5M FY25 FY26

Net Income Annual

-15M -10M -5M 0 5M 10M 15M FY25: -2.5M FY26: -13.8M FY25 FY26

Cost of Revenue Annual

0 2K 4K 6K FY25: 5K FY26: 0 FY25 FY26

Operating Cash Flow Annual

-12M -8M -4M 0 4M 8M 12M FY25: -9.5M FY26: -10.8M FY25 FY26

Free Cash Flow Annual

-12M -8M -4M 0 4M 8M 12M FY25: -9.5M FY26: -10.8M FY25 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 900K 1.8M 2.7M FY25: 1.5M FY26: 2.6M FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-27.00 -18.00 -9.00 0.00 9.00 18.00 27.00 Q2 '25: -22.76 Q3 '25: -24.64 Q4 '25: -1.70 Q1 '26: -0.10 Q2 '26: 0.60 Q3 '26: 1.85 Q4 '26: -5.36 Q1 '27: -4.47 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.